Menopausal hot flushes and vascular health

Area of Science:

• Cardiovascular Health
• Endocrinology
• Menopause Research

Background:

• Hot flushes affect ~75% of postmenopausal women, with hormone therapy (HT) being the most effective treatment.
• Observational studies suggest HT protects against cardiovascular disease (CVD), while randomized trials show increased CVD risk.
• Hot flushes are associated with altered vascular function and sympathetic nervous system activity, potentially explaining the discrepancy between study types.

Purpose of the Study:

• To investigate the cardiovascular implications of hot flushes in postmenopausal women.
• To assess the effects of hormone therapy, specifically estradiol, on endothelial function and blood pressure in relation to hot flushes.
• To compare the safety and efficacy of oral versus transdermal estradiol administration.

Main Methods:

• Prospective study design.
• Endothelial function testing and ambulatory blood pressure monitoring.
• Evaluation of estradiol (oral and transdermal) with and without medroxyprogesterone acetate in flushing and non-flushing women.

Main Results:

• Hot flushes were associated with a vasodilatory effect during endothelial testing, correlating with severity.
• Night-time hot flushes preceded transient increases in ambulatory blood pressure, but diurnal blood pressure remained unaffected.
• Oral estradiol showed no adverse effects on endothelial function in women with hot flushes, but caused vasoconstriction in non-flushing women; transdermal estradiol did not.
• Medroxyprogesterone acetate mitigated the vasoconstrictive effect of oral estradiol.

Conclusions:

• Hot flushes are linked to specific vascular changes, including transient blood pressure elevations.
• Both oral and transdermal estradiol are safe for managing hot flushes in postmenopausal women.
• Transdermal estradiol may be preferable for non-flushing women, particularly for bone protection, to avoid potential vasoconstrictive effects.